December 2017 FDA Recall Delflex by Fresenius Medical Care Renal Therapies Group, Llc
D-0604-2018 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Fresenius Medical Care Renal Therapies Group, Llc on December 20, 2017 for the product Delflex. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in Product was distributed throughout the United States to patients and clinics. and the recall is currently terminated.

Recall Number: D-0604-2018

Reason for Recall
Lack of Assurance of Sterility: Leakage of the peritoneal dialysis (PD) solution bag.
Initiated
12-20-2017
Reported
03-28-2018
Quantity
3,734 cases

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Medical Care Renal Therapies Group, LLC
Product was distributed throughout the United States to patients and clinics.
DELFLEX Peritoneal Dialysis Solution, 2.5% Low Mg/Low Ca Single Bag, packaged in a) 3L (4 pack, NDC 49230-209-30), b) 2 L(6 pack NDC 49230-209-23), Rx only, Fresenius Medical Care NA, Waltham, MA 02451.

Batch or Lot Expiration Information

Lot# : a) 17KU03006, 7KU03007; b) 17KU03004, 17KU03005, Exp.08/2019